Article

Primary drug resistance in South Africa: data from 10 years of surveys.

Africa Centre for Health and Population Studies, Doris Duke Medical Research Institute, Nelson Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
AIDS research and human retroviruses (Impact Factor: 2.46). 01/2012; 28(6):558-65. DOI: 10.1089/AID.2011.0284
Source: PubMed

ABSTRACT HIV-1 transmitted drug resistance (TDR) could reverse the gains of antiretroviral rollout. To ensure that current first-line therapies remain effective, TDR levels in recently infected treatment-naive patients need to be monitored. A literature review and data mining exercise was carried out to determine the temporal trends in TDR in South Africa. In addition, 72 sequences from seroconvertors identified from Africa Centre's 2010 HIV surveillance round were also examined for TDR. Publicly available data on TDR were retrieved from GenBank, curated in RegaDB, and analyzed using the Calibrated Population Resistance Program. There was no evidence of TDR from the 2010 rural KwaZulu Natal samples. Ten datasets with a total of 1618 sequences collected between 2000 and 2010 were pooled to provide a temporal analysis of TDR. The year with the highest TDR rate was 2002 [6.67%, 95% confidence interval (CI): 3.09-13.79%; n=6/90]. After 2002, TDR levels returned to <5% (WHO low-level threshold) and showed no statistically significant increase in the interval between 2002 and 2010. The most common mutations were associated with NNRTI resistance, K103N, followed by Y181C and Y188C/L. Five sequences had multiple resistance mutations associated with NNRTI resistance. There is no evidence of TDR in rural KwaZulu-Natal. TDR levels in South Africa have remained low following a downward trend since 2003. Continuous vigilance in monitoring of TDR is needed as more patients are initiated and maintained onto antiretroviral therapy.

0 Followers
 · 
148 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. In the face of increasing HIV/AIDS prevalence in subSaharan Africa, we evaluate the effectiveness of ‘doublegloving’ during surgery as a means of protecting the surgeon operating on patients with a known or unknown HIV status. Methods. A prospective study was conducted to determine the rate of glove puncture and intraoperative injury in categories of patients with known positive, known negative or unknown HIV status. Results. The surgeon and the first assistant double-gloved in all the 1 050 procedures performed between 2009 and 2013, and a total of 8 400 surgical gloves were used. Sixty-nine patients (6.6%) were HIV-positive, 29 patients (2.8%) were HIV-negative, and the HIV status was unknown for the remaining 952 patients (90.7%). The overall glove puncture rate in the study was 14.5%. The glove puncture rate was 0%, 31% and 15% for HIV-positive, HIV-negative and HIV status unknown, respectively, and this difference was statistically significant. The mean operating time in the group with glove punctures was 148 min (95% confidence interval (CI) 135 - 161), while mean operating time in the group without glove puncture was 88 min (95% CI 84 - 92). Conclusion. Double-gloving offers protection against intraoperative injury. Knowing the HIV status of the patient offers additional protection to the operating surgeon. While we recommend routine double-gloving for surgeons working in HIVprevalent patient populations, we also advocate for the routine screening for HIV in all surgical patients. S Afr J HIV Med 2014;15(4):144-147. DOI:10.7196/SAJHIVMED.1050
    Southern African Journal of HIV Medicine 12/2014; 15(4):144-147. DOI:10.7196/SAJHIVMED.1050 · 0.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aim To present a systematic review that evaluates the contributions of the INDEPTH Network of health and demographic surveillance systems (HDSSs) to research efforts on prevention and treatment of HIV/AIDS in low- and middle-income countries. Methods Publication titles were sent to INDEPTH by member centres. These were uploaded onto the Zotero research tool from different databases (most from PubMed). We searched for publications using the keyword “HIV” and the publication date. The 540 relevant papers were all published in peer-reviewed English language journals between 1999 and 2012. For a paper to be included in this study it must have extensively tackled the issue of HIV (1), prevention (2) and challenges associated with the treatment. After a thorough review, 89 papers were finally selected. Results Consistent condom use has been found to be highly protective against HIV infection. Although women feel at risk of contracting HIV from their partners and many women knew about condoms, they were unable to use them due to the partner's refusal. Infection with STDs is associated with HIV infection, populations with high rates of STDs and high-risk sexual behaviour, interventions to treat STDs can help prevent HIV transmission. The study also found that mother-to-child transmission was 2.7 times higher in infants breastfed for more than six months than in those breastfed for less than six months. The study found that the most promising prevention intervention discovered so far is male circumcision. Conclusion INDEPTH member centres have tracked the course of the HIV/AIDS epidemic in sub-Saharan Africa. They have analysed how the virus is transmitted and how it impacts families, communities and economies. Prevention and treatment policies and technologies have also come under scrutiny, including prevention of mother-to-child transmission of HIV, male circumcision, behaviour change polices, antiretroviral treatment and other key interventions. The robust and extensive data HDSSs have generated provide critical insights to policy-makers as the epidemic moves into its fourth decade.
    07/2014; 14(1). DOI:10.1016/j.hivar.2014.06.004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Worldwide circulating HIV-1 genomes show extensive variation represented by different subtypes, polymorphisms and drug-resistant strains. Reports on the impact of sequence variation on antiretroviral therapy (ART) outcomes are mixed. In this review, we summarize relevant published data from both resource-rich and resource-limited countries in the last 10 years on the impact of HIV-1 sequence diversity on treatment outcomes. The prevalence of transmission of drug resistant mutations (DRMs) varies considerably, ranging from 0% to 27% worldwide. Factors such as geographic location, access and availability to ART, duration since inception of treatment programs, quality of care, risk-taking behaviors, mode of transmission, and viral subtype all dictate the prevalence in a particular geographical region. Although HIV-1 subtype may not be a good predictor of treatment outcome, review of emerging evidence supports the fact that HIV-1 genome sequence-resulting from natural polymorphisms or drug-associated mutations-matters when it comes to treatment outcomes. Therefore, continued surveillance of drug resistant variants in both treatment-naïve and treatment-experienced populations is needed to reduce the transmission of DRMs and to optimize the efficacy of the current ART armamentarium.
    Viruses 10/2014; 6(10):3855-3872. DOI:10.3390/v6103855 · 3.28 Impact Factor

Full-text (2 Sources)

Download
37 Downloads
Available from
May 21, 2014